Loading…

Loading grant details…

Completed HORIZON European Commission

Lassie: The first-ever painless breath analyser for people with diabetes, a breakthrough in blood glucose monitoring

€8.71M EUR

Funder European Commission
Recipient Organization Boydsense
Country France
Start Date Aug 01, 2022
End Date Dec 31, 2025
Duration 1,248 days
Number of Grantees 1
Roles Coordinator
Data Source European Commission
Grant ID 190162033
Grant Description

Today, dogs are used to detect high and low blood glucose, cancers and are tested for coronavirus.The new Lassie breath analyser BOYDSense will put the power of a dogs nose into peoples hands and give them access to gentle health monitoring.Lassie starts with diabetes as it is an immense burden for 40 million people in Europe.

Current glucose monitoring technologies are underused because they are highly invasive, expensive, stigmatising and generate a lot of waste.Lassie will transform this situation by making measurements painless, simple, discreet and cost-effective without any consumables.

By analysing Volatile Organic Compounds (VOCs) in the breath, Lassie will calculate blood glucose value within current accuracy standard.

As a result, Lassie users will test earlier in the disease and more frequently, leading to better diabetes management and significant cost savings. EIC Accelerator will put BOYDSense on track to become a global leader in non-invasive diabetes monitoring.

All Grantees

Boydsense

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant